Publications by authors named "Lennard Lee"

Claim this Profile
C
Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.
Robert A Watson, Darcy Ward, Pippa Corrie, Elisa Fontana, William Ince, Siow-Ming Lee, Lennard Lee

Lancet Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiative.
Nathan Appanna, Rosie Mew, Sophie Williams, Thomas Starkey, Grisma Patel, Lennard Lee

Int J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.
Igor Aurer, Paul Moss, Michel Goldman, Mark Tuthill, Hermann Einsele, Lennard Lee

Oncologist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent SAGE as an example of effective public dialogue on scientific research.
Trisha Greenhalgh, Anthony Costello, Sheena Cruickshank, Stephen Griffin, Aris Katzourakis, Lennard Lee

Nat Protoc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical referral to the NHS following multi-cancer early detection test results from the NHS-Galleri trial.
Ian Lowenhoff, Saoirse Dolly, Rebecca Dowinton Smith, Sara Hiom, Liz Holmes, Lennard Y W Lee

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles.
Meredith Leston, José M Ordóñez-Mena, Mark Joy, F D Richard Hobbs, Simon de Lusignan, Lennard Y W Lee

EClinicalMedicine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccine trial evaluations: immunobridging and potential immunological endpoints.
Ahmed Hussain, Benjamin Moxley-Wyles, Michael Bryan, Alex Gordon-Weeks, Ibrahem Al-Obaidi, Lennard Lee

Immunother Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK cancer vaccine advance - Recognising and realising opportunities.
Charles Craddock, Philip Earwaker, Matthew Fittall, Elisa Fontana, Divya Ganesh, Lennard Lee, Rebecca Lee, Siow-Ming Lee

Camb Prism Precis Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies now.
Antonio Pagliuca, Sundeep Kaul, Carl S Goodyear, Lennard Lee

Infect Dis (Lond)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network.
Meredith Leston, Debasish Kar, Anna Forbes, Gavin Jamie, Rashmi Wimalaratna, Lennard Y W Lee

Front Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens.
Pedro Cruz, Jie Min Lam, Jehad Abdalla, Samira Bell, Jola Bytyci, Lennard Y W Lee

Vaccines (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study.
Meredith Leston, José Ordóñez-Mena, Mark Joy, Simon de Lusignan, Richard Hobbs, Lennard Lee

JMIR Res Protoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in England.
Rebecca Smittenaar, Samantha L Quaife, Christian von Wagner, Thomas Higgins, Earl Hubbell, Lennard Lee

J Epidemiol Community Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review.
Jola Bytyci, Yuxin Ying, Lennard Y W Lee

Immun Inflamm Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized cancer vaccines versus surveillance after adjuvant chemotherapy for surgically resected high-risk stage 2 and stage 3 colorectal cancer: protocol for a randomized trial.
Robert P Jones, Lennard Y W Lee, Pippa G Corrie, Sarah Danson, Dale Vimalachandran

Br J Surg· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exiting the pandemic together: achieving global immunity and equity.
Yuxin Ying, Jola Bytyci, Lennard Yw Lee

Oncoscience· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).
Thomas Starkey, Maria C Ionescu, Michael Tilby, Martin Little, Emma Burke, Alvin J X Lee, Siow Ming Lee, Lennard Y W Lee

Sci Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID-19 in immunocompromised patients.
Rhea Suribhatla, Thomas Starkey, Maria C Ionescu, Antonio Pagliuca, Alex Richter, Lennard Y W Lee

Br J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.
Matthew Fittall, Justin Liu, James Platt, Maria Ionescu, Remarez Sheehan, Lennard Y W Lee

Br J Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SARS-CoV-2 Antibody Level With Risk of Infection or Hospitalization-Reply.
Thomas Starkey, Michael Tilby, Lennard Y W Lee

JAMA Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team.
Nathan Appanna, Grisma Patel, Emma Burke, Alexander Burnett, James Clark, Lennard Y W Lee

Int J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.
Lennard Y W Lee, Michael Tilby, Thomas Starkey, Maria C Ionescu, Alex Burnett, Alvin J X Lee, Siow Ming Lee

JAMA Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.
Lennard Y W Lee, Maria C Ionescu, Thomas Starkey, Martin Little, Michael Tilby, Alvin Jx Lee, Siow M Lee

Eur J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review.
Youssra Al Hajji, Harriet Taylor, Thomas Starkey, Lennard Y W Lee, Michael Tilby

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lennard Y W Lee, Thomas Starkey, Maria C Ionescu, Martin Little, Michael Tilby, Alvin J X Lee, Siow Ming Lee

Lancet Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis